Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, February 25, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - THURSDAY, NOVEMBER 14TH, 2013
Previous Mid Day Report Next Mid Day Report >>>

DOW 15857.08 35.45 (0.22%) | NASDAQ 3963.22 -2.36 (-0.06%) | S&P 500 1787.94 5.94 (0.33%)
Time of Screening : 11/14/2013 11:55:40 AM         Report Released : 11/14/2013 1:06:50 PM
Price is: Above 52W High and Less Than 52W High but within 10% of the 52 Week High
Volume Is: At least 57.5% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(50 DAV)
52 Wk Hi
% From Hi
Date
Featured
Price
Featured
Pivot Point
Max Buy
SFUN - NYSE
Soufun Hldgs Ltd Ads A
$64.08 -3.35
-4.97%
$68.42 1,644,209
109.21% of 50 DAV
50 DAV is 1,505,500
$67.81
-5.50%
10/17/2013 $58.02 PP = $53.87
MB = $56.56
Most Recent Note - 11/14/2013 12:45:37 PM
G - Powered to new 52-week highs with 4 consecutive gains, getting extended from its prior base. Disciplined investors avoid chasing extended stocks. Prior highs in the $59 area define initial support to watch.
>>> The latest Featured Stock Update with an annotated graph appeared on 11/8/2013. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M

Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
ALGN - NASDAQ - HEALTH SERVICES - Medical Appliances & Equipment
Align Technology Inc
$55.10 -3.28
-5.62%
$55.95 $60.00 -8.17% 2,035,176
187.33%
1,086,400
Most Recent Note for ALGN - 11/14/2013 12:04:11 PM
Reported +62% earnings on +21% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Gapped down today, retreating from its 52-week high after stubbornly holding its ground in recent week. Prior mid-day reports cautioned members - "The past 5 quarterly comparisons through Jun '13 have been below the +25% minimum earnings guideline (C criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ANIK - NASDAQ - DRUGS - Biotechnology
Anika Therapeutics Inc
$30.76 -0.47
-1.50%
$31.90 $31.87 -3.48% 144,003
72.69%
198,100
Most Recent Note for ANIK - 11/14/2013 12:05:37 PM
Hovering near its 52-week high today, stubbornly holding its ground following considerable volume-driven gains. No overhead supply remains to act as resistance. Reported earnings +200% on +20% sales revenues for the Sep '13 quarter, above the +25% minimum earnings guideline for a 4th consecutive quarterly comparison (C criteria). Prior mid-day reports cautioned members - "Its up and down annual earnings (A criteria) history leaves fundamental concerns. Recently found support near its 50 DMA line. In the past year it went through a deep consolidation below its 200 DMA line then rebounded impressively and topped its 2012 high ($17.70)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
BABY - NASDAQ - HEALTH SERVICES - Medical Appliances & Equipment
Natus Medical Inc
$21.14 -0.20
-0.91%
$21.53 $21.59 -2.11% 144,103
62.76%
229,600
Most Recent Note for BABY - 11/14/2013 12:08:07 PM
Perched at its 52-week high today after a volume-driven spurt of gains. Held its ground stubbornly following a considerable "breakaway gap" on 10/24/13. Prior mid-day reports cautioned members - "The 5 latest quarterly comparisons through Sep '13 showed earnings increases above the +25% minimum guideline (C criteria). Its up and down annual earnings (A criteria) history is cause for concern. It survived but failed to impress since dropped from the Featured Stocks list on 10/07/08."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
BOFI - NASDAQ - BANKING - Savings & Loans
B O F I Holding Inc
$72.02 +2.89
4.17%
$72.16 $71.39 0.88% 133,262
59.49%
224,000
Most Recent Note for BOFI - 11/14/2013 12:09:47 PM
Rebounded above its 50 DMA line with a volume-driven gain when last noted and hitting a new 52-week high today. Reported earnings +27% on +15% sales revenues for the quarter ended September 30, 2013 but fundamental concerns remain. Noted in prior mid-day reports with caution - "It has earned high ranks, however a downturn in its FY '11 earnings was previously noted as a flaw with respect to the A criteria."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
BRLI - NASDAQ - HEALTH SERVICES - Medical Laboratories & Researc
Bio Reference Labs Inc
$35.57 -0.37
-1.03%
$36.13 $35.98 -1.14% 268,137
136.94%
195,800
Most Recent Note for BRLI - 11/14/2013 12:13:43 PM
Hitting a new 52-week high with a spurt of gains backed by near average volume. Reported earnings +18% on +16% sales revenues, below the +25% minimum guideline (C criteria) and fundamental concerns remain. Undercut its 200 DMA line during its choppy consolidation then rebounded since last noted in the 1/23/13 mid-day report with caution.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CBPO - NASDAQ - DRUGS - Biotechnology
China Biologic Products
$29.44 +0.44
1.52%
$29.98 $31.15 -5.49% 41,825
208.08%
20,100
Most Recent Note for CBPO - 11/14/2013 12:17:04 PM
Perched near its 52-week high today after choppy consolidation since last noted in the 3/14/13 mid-day report with caution. Reported earnings +4% on +0% sales for the Sep 13 quarter, and earnings increases have been below the +25% minimum necessary to satisfy the C criteria. Waning annual earnings increases in FY '10 and '11 were noted as a flaw concerning the A criteria.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CLFD - NASDAQ - TELECOMMUNICATIONS - Cables / Satalite Equipment
Clearfield Inc
$17.34 -0.22
-1.25%
$18.28 $17.70 -2.03% 84,624
84.79%
99,800
Most Recent Note for CLFD - 11/14/2013 12:19:48 PM
Hit another new 52-week high today after a volume-driven gain noted in the prior mid-day report. Found support at its 50 DMA line following a recent wave of distributional pressure. Made gradual progress since noted in prior mid-day reports repeatedly with caution - "Its quarterly and annual earnings (C and A criteria) history is not a match with the fact-based system's fundamental guidelines. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied.'"
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
EDU - NYSE - DIVERSIFIED SERVICES - Education &; Training Services
New Orientl Edu&Tech Ads
$27.52 +0.60
2.21%
$27.65 $28.40 -3.12% 814,357
77.39%
1,052,300
Most Recent Note for EDU - 11/14/2013 12:22:08 PM
Consolidating above its 50 DMA line since last noted in the 10/24/13 mid-day report while hitting its 52-week high - "Reported earnings +29% on +16% sales revenues for the Aug '13 quarter, but fundamental concerns remain. Reported earnings +38% on +27% sales revenues for the May '13 quarter. Earnings in the prior 3 quarterly comparisons through Feb '13 were below the +25% minimum guideline (C criteria). This China-based firm survived but failed to impress since dropped from the Featured Stocks list on 11/17/08."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HAIN - NASDAQ - FOOD & BEVERAGE - Processed & Packaged Goods
Hain Celestial Group
$84.41 -0.60
-0.70%
$85.35 $88.36 -4.48% 380,985
62.81%
606,600
Most Recent Note for HAIN - 11/14/2013 12:24:26 PM
Found support after undercutting its 50 DMA line then rebounded to new highs since last noted with caution in the 9/13/13 mid-day report. Completed a Secondary Offering on 9/05/13. Earnings were above the +25% minimum guideline in the 5 latest quarterly comparisons through Sep '13 satisfying the C criteria. Prior reports cautioned - "A downturn in FY '09 and FY '10 is a flaw with respect to the A criteria."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HTHT - NASDAQ - LEISURE - Lodging
China Lodging Group Ads
$25.49 +0.80
3.24%
$25.70 $24.90 2.37% 156,596
98.99%
158,200
Most Recent Note for HTHT - 11/14/2013 12:26:43 PM
Reported earnings +30% on +32% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Hitting another new 52-week high with today's volume-driven gain adding to a recent spurt. Found support above prior highs during its consolidation since noted in the 10/22/13 mid-day report with caution after volume-driven gains - "Cleared the previously noted large and orderly cup-with-handle base formed since noted in the 2/06/13 mid-day report with caution - 'Little resistance remains due to overhead supply. Reported strong sales and earnings increases in the Jun and Sep '12 quarters, but prior quarterly and annual earnings (A criteria) history included a downward turn in FY '11, making it not a good match with the fact-based investment system's guidelines.'"
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MEOH - NASDAQ - CHEMICALS - Specialty Chemicals
Methanex Corp
$62.89 +0.50
0.80%
$63.56 $62.56 0.53% 319,325
60.14%
531,000
Most Recent Note for MEOH - 11/14/2013 12:27:51 PM
Perched at its 52-week high and getting more extended from any sound base. Reported earnings +221% on +25% sales for the Sep '13 quarter, its 3rd consecutive quarterly comparison with earnings above the +25% minimum (C criteria), however fundamental concerns remain. Prior mid-day reports cautioned - "Earnings growth history is not a good match with the fact-based investment system's C and A criteria."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MOV - NYSE - CONSUMER DURABLES - Recreational Goods, Other
Movado Group Inc
$45.96 -0.79
-1.69%
$46.67 $48.50 -5.24% 62,816
59.65%
105,300
Most Recent Note for MOV - 11/14/2013 12:28:55 PM
Still consolidating above prior highs and its 50 DMA line after hitting new highs with a volume-driven gain last week. Prior mid-day reports cautioned members - "Quarterly earnings (C criteria) history has not been strong and steady and the previously noted loss in FY '10 is a flaw in the Retail/Wholesale - Jewelry firm's annual earnings (A criteria) history."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
OPEN - NASDAQ - INTERNET - Internet Software & Services
Opentable Inc
$85.64 +2.21
2.65%
$86.76 $83.45 2.63% 683,287
114.53%
596,600
Most Recent Note for OPEN - 11/14/2013 12:30:56 PM
Hitting new 52-week highs with today's 5th consecutive gain. Bullish action has continued since a considerable gap up gain on 11/06/13 as it rebound from below its 50 DMA line. Reported earnings +19% on +17% sales revenues for the Sep '13 quarter, below the +25% minimum earnings guideline (C criteria) for its 4th consecutive quarterly comparison. Noted in prior mid-day reports with caution - "It faces additional resistance due to overhead supply up through the $118 level. It went through a long and deep consolidation since dropped from the Featured Stocks list on 5/10/11."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PEGA - NASDAQ - COMPUTER SOFTWARE & SERVICES - Business Software & Services
Pegasystems Inc
$45.74 -3.21
-6.56%
$48.62 $49.47 -7.54% 150,919
172.28%
87,600
Most Recent Note for PEGA - 11/14/2013 12:35:03 PM
Pulling back today, and prior highs in the $40 area define initial support. Following a strong finish and technical breakout on 11/12/13 there was a "breakaway gap" for a considerable gain after reporting earnings +154% on +20% sales revenues for the Sep '13 quarter. It was noted with caution in the 10/28/13 mid-day report while finding support near its 50 DMA line - "Fundamental concerns remain, as its quarterly earnings history has been strong in recent quarterly comparisons through Jun '13, but prior quarterly and annual earnings have not been strong and steady enough to meet the investment system's guidelines. Survived but failed to impress since dropped from the Featured Stocks list on 4/23/10."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PMC - NYSE - HEALTH SERVICES - Drug Services
Pharmerica Corp
$20.71 +0.46
2.27%
$20.81 $20.26 2.22% 152,033
59.64%
254,900
Most Recent Note for PMC - 11/14/2013 12:39:48 PM
Hitting a new 52-week high today, adding to a spurt of gains following a considerable gap up and technical breakout on 11/05/13. The 3 latest quarterly comparisons through Sep '13 showed earnings increases above the +25% minimum guideline but with waning sales revenues versus the year ago periods indicating no growth in demand for new (N criteria) products or services. Annual earnings (A criteria) history has not been strong and steady.

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PRU - NYSE - INSURANCE - Life Insurance
Prudential Financial Inc
$89.10 +1.27
1.45%
$89.31 $87.87 1.40% 1,270,050
60.12%
2,112,500
Most Recent Note for PRU - 11/14/2013 12:41:02 PM
Hitting new 52-week highs with a spurt of gains. Reported earnings +85% on -18% sales revenues for the Sep '13 quarter, and fundamental concerns remain. Noted in the 9/19/13 mid-day report with caution - "Erratic quarterly and annual earnings history (C and A criteria) and erratic sales revenues growth history is not a match with the guidelines of the fact-based investment system."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PSMT - NASDAQ - RETAIL - Drug Stores
Pricesmart Inc
$114.81 -7.14
-5.85%
$116.50 $124.67 -7.91% 135,616
107.63%
126,000
Most Recent Note for PSMT - 11/14/2013 12:42:41 PM
Gapped down today, retreating from its 52-week high after holding its ground following a spurt of volume-driven gains. The 11/11/13 mid-day report cautioned members - "Reported earnings +19% on +14% sales revenues for the Aug '13 quarter. The 2 prior quarterly comparisons also showed earnings below the +25% minimum guideline (C criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
SLXP - NASDAQ - DRUGS - Drug Related Products
Salix Pharmaceuticals
$85.39 +0.05
0.06%
$86.83 $86.36 -1.12% 836,360
106.79%
783,200
Most Recent Note for SLXP - 11/14/2013 12:47:48 PM
Stubbornly held its ground and rallied further following a "breakaway gap" on 11/08/13, rising with no resistance due to overhead supply. The 11/11/13 mid-day report cautioned - "Reported earnings +16% on +29% sales revenues for the quarter ended September 30, 2013 versus the year ago period. The 2 prior quarterly comparisons were above the +25% minimum earnings guideline (C criteria), but prior quarterly and annual its earnings history has been erratic and is not a match with the fact-based investment system's guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
SPR - NYSE - FINANCIAL SERVICES - Closed-End Fund - Debt
Spirit Aerosystems Hldgs
$30.33 +0.27
0.90%
$30.68 $30.07 0.86% 536,139
62.90%
852,300
Most Recent Note for SPR - 11/14/2013 12:51:32 PM
Hitting new 52-week highs with a spurt of gains. Reported earnings +18% on +10% sales revenues for the Sep '13 quarter, below the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been up and down.

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
SQI - NASDAQ - INTERNET - Internet Software & Services
Sciquest Inc
$25.26 +0.26
1.04%
$25.35 $26.00 -2.85% 80,375
71.25%
112,800
Most Recent Note for SQI - 11/14/2013 12:54:39 PM
Powered higher on 11/06/13 with a big volume-driven gain and it has been holding its ground perched within close striking distance of its 52-week high and previously stubborn resistance in the $25-26 area. Last noted in the 11/07/13 mid-day report with caution - "Quarterly earnings in the 3 latest comparisons through Sep '13 satisfied the C criteria (above the +25% minimum earnings guideline. Annual earnings history is not a match with the fact-based investment system's guidelines (A criteria). Found support at its 200 DMA line during its consolidation since last noted in the 7/22/13 mid-day report with caution."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TARO - NYSE - DRUGS - Drug Manufacturers - Other
Taro Pharmaceutical Inds
$90.45 +1.21
1.36%
$92.23 $90.88 -0.47% 22,333
81.21%
27,500
Most Recent Note for TARO - 11/14/2013 12:55:36 PM
Powering to new 52-week highs with considerable volume-driven gains this week. Reported earnings +47% on +28% sales revenues for the Sep '13 quarter, but fundamental concerns remain. Prior mid-day reports repeatedly cautioned members - "Reported earnings -6% on -4% sales revenues for the Jun '13 quarter, below the +25% minimum guideline (C criteria). The Israel-based Medical - Generic Drugs firm faced no resistance due to overhead supply when noted in prior mid-day reports with caution. The number of top-rated funds owning its shares from 2 in Mar '12 to 23 as of Jun '13, a reassuring sign concerning the I criteria."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TRN - NYSE - TRANSPORTATION - Railroads
Trinity Industries Inc
$55.58 +0.31
0.56%
$56.00 $55.29 0.52% 613,493
60.09%
1,020,900
Most Recent Note for TRN - 11/14/2013 12:57:46 PM
Hitting another new 52-week high today. Held its ground after volume-driven gains when last noted in the 11/01/13 mid-day report with caution - "Quarterly earnings increases through Sep '13 have been above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has not been a match with the fact-based system's winning models."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
VIAB - NASDAQ - MEDIA - Entertainment - Diversified
Viacom Inc Cl B
$81.37 -1.76
-2.12%
$83.49 $86.06 -5.45% 3,358,152
125.67%
2,672,200
Most Recent Note for VIAB - 11/14/2013 1:01:28 PM
Consolidating below its 50 DMA line, and prior lows in the $79 area define the next near-term support to watch. Reported better earnings increases in the Jun and Sep '13 quarters but fundamental concerns remain. Prior quarterly and annual earnings history (C criteria) is not a match with the fact based investment system's guidelines. Annual earnings (A criteria) have been improving after a downturn in FY '09.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
WILC - NASDAQ - WHOLESALE - Food Wholesale
G Willi Food Intl Ltd
$8.20 -0.05
-0.61%
$8.30 $8.40 -2.38% 18,731
69.89%
26,800
Most Recent Note for WILC - 11/14/2013 1:04:54 PM
Perched at its 52-week high after a spurt of volume-driven gains helped it rally from a long flat base. Reported earnings above the +25% minimum guideline (C criteria) in the 3 latest quarterly comparisons through Sep '13, but fundamental concerns remain. Traded in a very tight range near its 50 DMA line and built a long flat base since noted in the 5/17/13 mid-day report with caution - "Earnings history is not a match with the fact-based investment system's guidelines (C and A criteria). Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. It survived but failed to impress since last noted in the 3/02/10 mid-day report."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
WX - NYSE - DRUGS - Drug Manufacturers - Other
Wuxi Pharmatech Inc Ads
$31.92 +1.00
3.23%
$31.98 $32.92 -3.04% 387,909
76.05%
510,100
Most Recent Note for WX - 11/14/2013 1:06:32 PM
Perched at its 52-week high today and no resistance remains due to overhead supply, but it is extended from any sound base pattern. Reported earnings +31% on +17% sales revenues for the Sep '13 quarter, a 2nd comparison above the +25% minimum guideline, but fundamental concerns remain. This Chinese Medical/Dental Services firm's earnings history is not a match with the fact-based investment system's guidelines calling for the 3 or 4 most recent quarters to have earnings increases above the +25% guideline (C criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us